Microbial and AMR Development/Validation Partner
EMC offers potential access to a biobank of microbial isolates, as well as to clinical samples and patients.
Assist technology innovators in their bacterial, fungal and AMR technology development and validation
- Infection prevention
- Antimicrobial stewardship
- Microbial diagnostics
- Antimicrobial compound/strategy
- Removal antibiotics/bacteria
- Market entry
- Marketed product
- Joint Venture
- OTHER / NA
Infectious disease area:
- North America
- South America
Many different types of collaborations are available upon request.
EMC is aiding the development and validation of technologies that lead the way in innovation.
Expertise available in many areas including bacterial, mycobacterial, fungal and parasitic pathogens, as well as hospital acquired infections.